Related Experiment Video
Updated: Jan 28, 2026

Design and Synthesis of a Reconfigurable DNA Accordion Rack
Published on: August 15, 2018
Design, Synthesis, and Actions of an Innovative Bispecific Designer Peptide
Laura M G Meems1,2, Ingrid A Andersen1,2, Shuchong Pan1,2
1From the Cardiorenal Research Laboratory (L.M.G.M., I.A.A., S.P., G.H., Y.C., Y.Z., G.E.H., T.I., D.M.H., S.R.I., S.J.S., J.C.B.), Mayo Clinic, Rochester, MN.
A novel bispecific peptide, NPA7, simultaneously targets two key receptors to offer enhanced cardiorenal protective benefits. This designer peptide shows promise as a new therapeutic for cardiovascular diseases like heart failure and hypertension.
Area of Science:
- Cardiovascular Research
- Peptide Engineering
- Pharmacology
Background:
- Cardiovascular disease is the leading cause of global mortality despite current treatments.
- Peptide engineering offers innovative therapeutic strategies for various diseases.
- Bispecific therapeutics targeting multiple signaling pathways are a novel approach for cardiovascular disease.
Purpose of the Study:
- To engineer and characterize a novel bispecific peptide, NPA7, targeting both the particulate guanylate cyclase A (pGC-A) receptor and the Mas receptor (MasR).
- To evaluate the in vitro and in vivo efficacy of NPA7 as a potential cardiorenoprotective therapeutic for cardiovascular disease.
Main Methods:
- NPA7 was engineered by fusing a B-type natriuretic peptide (BNP) sequence with Angiotensin 1-7 (Ang 1-7).
- In vitro studies assessed NPA7's dual receptor activation via second messenger production and receptor interaction.
- In vivo studies in canines evaluated NPA7's biological actions, including its response to an MasR antagonist.
Main Results:
- Successful synthesis of NPA7, a bispecific activator for pGC-A and MasR, was confirmed.
- In canines, NPA7 demonstrated enhanced natriuretic, diuretic, systemic, and renal vasorelaxing properties.
- NPA7 exhibited superior effects compared to individual native ligands for pGC-A and MasR.
Conclusions:
- NPA7 is a novel bispecific designer peptide with demonstrated dual receptor-activating capabilities.
- NPA7 shows significant potential as a cardiorenal therapeutic agent for cardiovascular diseases, including hypertension and heart failure.
Related Concept Videos
Group Design
Factorial Design
Design Example: Designing a Residential Plumbing System
Design Example: Designing Water Slide
Bernoulli's principle determines the water's velocity along the slide....
Design Example: Design of an Irrigation Channel
Design Example

